AngioDynamics Inc. (NASDAQ:ANGO) currently has a daily average trading volume of 372.00K but it saw 274719 shares traded on Wednesday. With a market cap of 521.26M USD, stock’s current market price of $13.61 came falling about -7.04 while comparing to the previous closing price of $14.64. In past 52 weeks, the stock remained buoying in the range of price level as high as $30.00 and as low as $12.87. In the recent trading on the day, stock has struck highest price mark of $14.64 while lowest mark touched by it was $13.04.
Taking a look at 20-day trading activity of AngioDynamics Inc. (ANGO) gives us an average price of $13.97, while its current price level is -54.63% below from 52-week high level whereas it is 5.75% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $16.12 while that of 200 days or SMA-200 reads an average of $20.24. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.26% during that period while stretching the period over a month that decreases to 5.48%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 40.79 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Canaccord Genuity which upgraded the stock as “Buy” in its note to investors issued on October 15, 2021, recommending a price target of between $28 and $37 for it. Raymond James also issued its recommendations for the stock as it upgraded the price target for the stock is $18.
Over the week, ANGO’s stock price is moving -2.51% down while it is 3.42% when we observe its performance for the past one month. Year-to-date it is -50.65% down and over the past year, the stock is showing a downside performance of -51.67%.
The latest quarterly earnings report issued by the company was for quarter ended 8/30/2022, when its quarterly earnings per share (EPS) of -$0.06 beaten by the consensus estimate of -$0.02 for the same. In next quarter, company is expected to be making quarterly sales of $84.09 million as analysts are expecting the sales for current fiscal year at $342.5 million and seeing the company making $371.14 million in sales next year. Moreover, analysts are in estimates of $84.33 million for current-quarter revenue.
Currently, AngioDynamics Inc.’s total number of outstanding shares is 39.30M with 5.03% of that held by the insiders while 96.70% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -5.60% and return on equity (ROE) at -7.70%. It has a 100.81 of forward P/E ratio. Stock’s beta reads 0.73. Stock has a price to book (P/B) ratio of 1.29 while price to sale or P/S ratio amounts to 1.62. Its return on asset (ROA) is -5.90% on average.
A filing at the U.S. Securities and Exchange Commission revealed that iShares Core S&P Small Cap ETF came shrinking its share ownership by 0.08% in the AngioDynamics Inc. (ANGO) increasing its stake to 7.46% with control over 2232.0 shares in the company. As per SEC documents, iShares Core S&P Small Cap ETF sought 2,916,300 of company’s common stock of worth $41.09 million as per recent closing price of the stock. iShares Core S&P Small Cap ETF is not the only institutional holder which restructured its stake in AngioDynamics Inc., as Victory Sycamore Small Company Op picked 2,085,000 shares of worth $29.38 million to bring its holdings to a total of 0.12 million shares.